MBX Biosciences Inc (MBX) PT Raised to $88 at Truist Securities
Tweet
Share
E-mailGet Alerts MBX Hot Sheet
Price: $60.93 --0%
Rating Summary:
11 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Rating Summary:
11 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Join SI Premium – FREE
Truist Securities analyst Srikripa Devarakonda raised the price target on MBX Biosciences Inc (NASDAQ: MBX) to $88.00 (from $70.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Downgrades Barclays Plc (BARC:LN) (BCS) to Equalweight
- Unicredit SpA (UCG:IM) (UNCFF) PT Raised to EUR105 at Morgan Stanley
- Credit Agricole SA (ACA:FP) (CRARY) PT Raised to EUR21 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
